Skip to main content
eScholarship
Open Access Publications from the University of California

Macrophage PI3Kγ Drives Pancreatic Ductal Adenocarcinoma Progression.

  • Author(s): Kaneda, Megan M
  • Cappello, Paola
  • Nguyen, Abraham V
  • Ralainirina, Natacha
  • Hardamon, Chanae R
  • Foubert, Philippe
  • Schmid, Michael C
  • Sun, Ping
  • Mose, Evangeline
  • Bouvet, Michael
  • Lowy, Andrew M
  • Valasek, Mark A
  • Sasik, Roman
  • Novelli, Francesco
  • Hirsch, Emilio
  • Varner, Judith A
  • et al.
Abstract

Unlabelled

Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with a low 5-year survival rate, yet new immunotherapeutic modalities may offer hope for this and other intractable cancers. Here, we report that inhibitory targeting of PI3Kγ, a key macrophage lipid kinase, stimulates antitumor immune responses, leading to improved survival and responsiveness to standard-of-care chemotherapy in animal models of PDAC. PI3Kγ selectively drives immunosuppressive transcriptional programming in macrophages that inhibits adaptive immune responses and promotes tumor cell invasion and desmoplasia in PDAC. Blockade of PI3Kγ in PDAC-bearing mice reprograms tumor-associated macrophages to stimulate CD8(+) T-cell-mediated tumor suppression and to inhibit tumor cell invasion, metastasis, and desmoplasia. These data indicate the central role that macrophage PI3Kγ plays in PDAC progression and demonstrate that pharmacologic inhibition of PI3Kγ represents a new therapeutic modality for this devastating tumor type.

Significance

We report here that PI3Kγ regulates macrophage transcriptional programming, leading to T-cell suppression, desmoplasia, and metastasis in pancreas adenocarcinoma. Genetic or pharmacologic inhibition of PI3Kγ restores antitumor immune responses and improves responsiveness to standard-of-care chemotherapy. PI3Kγ represents a new therapeutic immune target for pancreas cancer. Cancer Discov; 6(8); 870-85. ©2016 AACR.This article is highlighted in the In This Issue feature, p. 803.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Main Content
Current View